Skip to main content
. Author manuscript; available in PMC: 2019 Jul 6.
Published in final edited form as: Lancet Respir Med. 2016 Jun 10;4(8):617–626. doi: 10.1016/S2213-2600(16)30121-7

Figure 1:

Figure 1:

Absolute change from baseline in ppFEV1 at each study visit for patients with baseline ppFEV1 <40 (A) or ≥40 (B), and for patients with screening ppFEV1 <70 (C) or ≥70 (D)

BL=baseline; CI=confidence interval; IVA=ivacaftor; LUM=lumacaftor; LS=least squares; ppFEV1=percent predicted forced expiratory volume in 1 second; q12h=once every 12 hours; qd=once daily.